GENERAL COMMENTS
To author, In the randomised controlled trial, the authors set out to assess whether preventative use of ondansetron can reduce the vomiting incidence when INF is combined with N2O for procedural sedation compared with placebo. If successful, the combination of INF and N2O with ondansetron would provide a new management strategy that will add to the current standard of care for paediatric procedural sedation.
First of all, this study has important clinical significance.
Secondly, design of the experiment system is reasonable and reliable. Major There is no any data result of the experiment in the article.
VERSION 1 -AUTHOR RESPONSE
1) We thank Reviewer #1 for a thorough evaluation of our paper. We have addressed concerns from Reviewer #1 in this section.
"The manuscript describes a well thought out and valid study. The protocol is written clearly and has no major flaws. Items of style rather than substance can always be identified. Such minor revisions do not add to the scientific worth of the protocol and do not serve the investigators well."
We thank Reviewer #1 for this positive review. We have not made any changes to the manuscript in response to the above comment.
2) We thank Reviewer #2 for a thorough evaluation of our paper. We have addressed concerns from Reviewer #2 in this section. "In the randomised controlled trial, the authors set out to assess whether preventative use of ondansetron can reduce the vomiting incidence when INF is combined with N2O for procedural sedation compared with placebo. If successful, the combination of INF and N2O with ondansetron would provide a new management strategy that will add to the current standard of care for paediatric procedural sedation. First of all, this study has important clinical significance. Secondly, design of the experiment system is reasonable and reliable."
We thank Reviewer #2 for this positive review. We have not made any changes to the manuscript in response to the above comment.
